NHS-BiotinBiotinyltation reagent CAS# 35013-72-0 |
- Sulfo-NHS-Biotin
Catalog No.:BCC3576
CAS No.:119616-38-5
- NHS-SS-Biotin
Catalog No.:BCC3581
CAS No.:142439-92-7
- Sulfo-NHS-SS-Biotin
Catalog No.:BCC3580
CAS No.:325143-98-4
- Biotin Hydrazide
Catalog No.:BCC3582
CAS No.:66640-86-6
- NHS-LC-Biotin
Catalog No.:BCC3579
CAS No.:72040-63-2
- Iodoacetyl-LC-Biotin
Catalog No.:BCC3584
CAS No.:93285-75-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 35013-72-0 | SDF | Download SDF |
PubChem ID | 434213 | Appearance | Powder |
Formula | C14H19N3SO5 | M.Wt | 341.38 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Biotin-NHS; Biotin N-hydroxysuccinimide ester; NHS-Biotin | ||
Solubility | >17.1mg/mL in DMSO | ||
Chemical Name | (2,5-dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoate | ||
SMILES | C1CC(=O)N(C1=O)OC(=O)CCCCC2C3C(CS2)NC(=O)N3 | ||
Standard InChIKey | YMXHPSHLTSZXKH-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H19N3O5S/c18-10-5-6-11(19)17(10)22-12(20)4-2-1-3-9-13-8(7-23-9)15-14(21)16-13/h8-9,13H,1-7H2,(H2,15,16,21) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | NHS-Biotin is the simplest NHS-ester activated biotinylation reagent used for intracellular labeling. | |||||
Targets | intracellular proteins |
Cell experiment: [1] | |
Cell lines | Bone marrow macrophages (BMMs) |
Preparation method | The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. |
Reacting condition | 180 μg/ml, 45 min |
Applications | Cells were washed in PBS-0.1M HEPES, and cell surface proteins were biotinylated using NHS-Biotin. (450 µg NHS-biotin in 2.5 mL PBS-0.1 M HEPES per 150 mm2 plate, and then incubated for 45 minutes at room temperature). Cells were washed gently 3 times with cold PBS and then lysed in lysis buffer (10 mM Tris, 150 mM NaCl, 1.0 mM CaCl, 0.02% NaN3 2×protease inhibitor cocktail, and 2% Renex). Protein concentrations in the lysates were determined by bicinchoninic acid reaction, and equal amounts of total protein were immunoprecipitated. |
Animal experiment: | |
Animal models |
|
Dosage form |
|
Application |
|
Other notes | Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1] McHugh K P, Hodivala-Dilke K, Zheng M H, et al. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. Journal of Clinical Investigation, 2000, 105(4): 433-440. |
NHS-Biotin Dilution Calculator
NHS-Biotin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9293 mL | 14.6464 mL | 29.2929 mL | 58.5857 mL | 73.2322 mL |
5 mM | 0.5859 mL | 2.9293 mL | 5.8586 mL | 11.7171 mL | 14.6464 mL |
10 mM | 0.2929 mL | 1.4646 mL | 2.9293 mL | 5.8586 mL | 7.3232 mL |
50 mM | 0.0586 mL | 0.2929 mL | 0.5859 mL | 1.1717 mL | 1.4646 mL |
100 mM | 0.0293 mL | 0.1465 mL | 0.2929 mL | 0.5859 mL | 0.7323 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
NHS-Biotin (C14H18O5N3S) is N-hydroxysuccinimido biotin. It is the shortest of three similar EZ-Link NHS-Biotin Reagents that enable simple and efficient biotinylation of antibodies, proteins and any other primary amine-containing biomolecules in solution. NHS-Biotin offers researchers the possibility of optimizing labeling and detection experiments where steric hindrance of biotin binding is an important factor. Because it is uncharged and contain simple alkyl-chain spacer arms, NHS-Biotin compound is membrane-permeable and useful for intracellular labeling.
NHS-Biotin is the most popular type of biotinylation reagent. NHS-activated biotins react efficiently with primary amino groups (-NH2) in alkaline buffers to form stable amide bonds. Proteins (e.g., antibodies) typically have several primary amines that are available as targets for labeling, including the side chain of lysine (K) residues and the N-terminus of each polypeptide.
Ref:
- Fouassier, L., Yun, C. C., Fitz, J. G. and Doctor, R. B. (2000). Evidence for Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) Self-association through PDZ-PDZ Interactions. J. Biol. Chem. 275, 25039-25045.
- Nunomura, W., Takakuwa, Y., Parra, M., Conboy, J.G., & Mohandas, N. (2000) Regulation of protein 4.1R, p55 and glycophorin C ternary complex in human erythrocyte membrane. J. Biol. Chem. 275(32): 24540-24546.
- Chiu, N.H. & T.K. Christopoulos. 1999. Two-site expression immunoassay using a firefly luciferase-coding DNA label. Clin. Chem. 45: 1954–1959..
- Cucurbitadienol
Catalog No.:BCN3342
CAS No.:35012-08-9
- 10beta-Hydroxycadina-4,11(13)-dien-12,8beta-olide
Catalog No.:BCN7435
CAS No.:35001-23-1
- 4alpha,6alpha-Dihydroxyeudesm-11(13)-en-12,8beta-olide
Catalog No.:BCN7431
CAS No.:35001-19-5
- Kurarinone
Catalog No.:BCN2985
CAS No.:34981-26-5
- Kuraridine
Catalog No.:BCN2988
CAS No.:34981-25-4
- Kushenol F
Catalog No.:BCN3798
CAS No.:34981-24-3
- Z-Val-OSu
Catalog No.:BCC2733
CAS No.:3496-11-5
- 3'',4''-Di-O-acetyl-2'',6''-di-O-p-coumaroylastragalin
Catalog No.:BCN6843
CAS No.:349545-02-4
- Dodonolide
Catalog No.:BCN4645
CAS No.:349534-73-2
- Methyl dodonate A
Catalog No.:BCN4646
CAS No.:349534-70-9
- Methyl dodonate A acetate
Catalog No.:BCN4647
CAS No.:349487-98-5
- Alda 1
Catalog No.:BCC6096
CAS No.:349438-38-6
- Brosimacutin G
Catalog No.:BCN3202
CAS No.:350221-50-0
- ent-17-Hydroxykaur-15-en-19-oic acid
Catalog No.:BCN4644
CAS No.:35030-38-7
- 2,5-Dihydroxyxanthone
Catalog No.:BCN7573
CAS No.:35040-32-5
- Obscuraminol C
Catalog No.:BCN1767
CAS No.:350484-95-6
- Obscuraminol D
Catalog No.:BCN1770
CAS No.:350484-99-0
- Obscuraminol E
Catalog No.:BCN1769
CAS No.:350485-00-6
- Obscuraminol F
Catalog No.:BCN1768
CAS No.:350485-01-7
- Obscuraminol B
Catalog No.:BCN1766
CAS No.:350485-82-4
- 4-Epi-curcumenol
Catalog No.:BCN3523
CAS No.:350602-21-0
- Isodemethylwedelolacton
Catalog No.:BCN2766
CAS No.:350681-33-3
- Dendocarbin A
Catalog No.:BCN5287
CAS No.:350986-74-2
- H-D-His-OH
Catalog No.:BCC2959
CAS No.:351-50-8
Assessment of solvent residues accessibility using three Sulfo-NHS-biotin reagents in parallel: application to footprint changes of a methyltransferase upon binding its substrate.[Pubmed:17968972]
J Mass Spectrom. 2008 Mar;43(3):360-70.
NHS-Biotin modification as a specific lysine probe coupled to mass spectrometry detection is increasingly used over the past years for assessing amino acid accessibility of proteins or complexes as an alternative when well-established methods are challenged. We present a strategy based on usage in parallel of three commercially available reagents (Sulfo-NHS-Biotin, Sulfo-NHS-LC-biotin, and Sulfo-NHS-LC-LC-biotin) to efficiently assess the solvent accessibility of amino acids using MALDI-TOF mass spectrometry. The same qualitative pattern of reactivity was observed for these three reagents on the THUMPalpha protein at four reagent/polypeptide molar ratios (2 : 1, 6 : 1, 13 : 1, and 26 : 1). Peptide assignment of the detected ions gains in accuracy because of the triple redundancy due to specific increments of monoisotopic mass. These reagents are a good alternative to isotope labeling when using only a single MALDI-TOF mass spectrometer. We observed that hydroxyl groups of serine and tyrosine residues were also modified by these Sulfo-NHS-Biotin reagents. The low amount of protein required and the method's simplicity make this procedure accessible and affordable in order to obtain topological information on proteins difficult to purify. This method was used to identify two lysine residues of the TrmG10 methyltransferase from Pyrococcus abyssi that were differentially reactive, modified in the protein but not in the tRNA-protein complex.
The beta chain of the GPIIb molecule on ruminant leukocytes and platelets is not labelled by the sulfo-NHS-biotin method.[Pubmed:8578739]
Vox Sang. 1995;69(3):248-9.
Glycoprotein (Gp)IIb/IIIa molecules have been immunoprecipitated from platelets and leukocytes of cattle, goat, horse, human, sheep and swine using specific monoclonal antibodies. The sulfo-NHS-Biotin (sulfosuccinimidobiotin) method used to label the proteins has been found unsuitable for labelling the beta chain of the ruminant GPIIb/IIIa molecule. The beta chain was present on ruminant leukocytes and platelets when immunoprecipitates were silver stained.